Cleared Traditional

K030636 - C-PORT

K030636 is an FDA 510(k) clearance for C-PORT, manufactured by Clinisurg Vascular Products, LLC. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K030636 · Clinisurg Vascular Products, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2003
Decision
97d
Days
Class 2
Risk

K030636 is an FDA 510(k) clearance for the C-PORT. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Clinisurg Vascular Products, LLC (Dallas, US). The FDA issued a Cleared decision on June 5, 2003 after a review of 97 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Clinisurg Vascular Products, LLC devices

FDA 510(k) Submission Details - K030636

510(k) Number K030636 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 2003
Decision Date June 05, 2003
Days to Decision 97 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 129d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 233
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K030636.
VAXCEL WITH PASV PORT (LOW PROFILE), MODELS 45-236 AND 45-238
K031844 · Boston Scientific Corp · Jul 2003
VAXCEL WITH PASV PORT, MODEL 45-213
K032008 · Boston Scientific Corp · Jul 2003
X-PROT DUO PORT
K032044 · C.R. Bard, Inc. · Jul 2003
OPTILOCK IMPLANTABLE ACCESS PORT, MODELS #1700-01, 1700-02, 1700-03, 1700-04 AND 1700-05
K021580 · LeMaitre Vascular, Inc. · Feb 2003
VAXCEL WITH PASV PORT
K030083 · Boston Scientific Corp · Jan 2003
BARDPORT X-PORT ISP PORT
K022983 · C.R. Bard, Inc. · Sep 2002